Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs. The FDA requires identical active ingredients, bioequivalence testing, and strict manufacturing controls. Over 90% of U.S. prescriptions are generics, saving $373 billion annually.
Learn exactly what the FDA requires for stability testing of generic drugs, including batch sizes, testing schedules, common rejection reasons, and 2025 updates. Understand how to avoid delays in ANDA approval.